Evidence map›Paper›PMID 38542101›Full record

ArticleInternational journal of molecular sciences2024

Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric Cancer.

Laura F Dagley, Jumana Yousef, Adele Preaudet, Andrea Loving, Andrew I Webb, Matthias Ernst, Tracy L Putoczki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Laura F DagleyThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.ORCID 0000-0003-4171-3712
Jumana YousefThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Adele PreaudetThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Andrea LovingLudwig Institute of Cancer Research, Melbourne, VIC 3052, Australia.
Andrew I WebbThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.
Matthias ErnstThe Olivia Newton John Cancer Research Institute, Melbourne, VIC 3084, Australia.ORCID 0000-0002-6399-1177
Tracy L PutoczkiThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.ORCID 0000-0003-1639-4932
The University of Melbourne · AULa Trobe University · AULudwig Cancer Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are a limited number of clinically useful serum biomarkers to predict tumor onset or treatment response in gastric cancer (GC). For this reason, we explored the serum proteome of the

Indexed as

Signal TransductionStomach NeoplasmsAnimalsBiomarkersBiomarkers, TumorCytokine Receptor gp130MiceBiomarkersBiomarkers, TumorCytokine Receptor gp130biomarkerInterleukin-11intestinal-type gastric cancermouse modelproteomics

Identifiers

PMID38542101
PMCPMC10970471
OpenAlexW4392588703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.